The specific HER2 receptor inhibitors reduce tumor cell growth by blocking the oncogenic growth factor receptor HER2. The effectivity of anti-HER2 drugs depends on the overexpression of the HER2 receptor, mostly as a result of gene amplification. Here, ERBB2 is linked to neoplasm.